摘要
肥胖是多种恶性肿瘤发生的重要危险因素,例如乳腺癌、子宫内膜癌、结直肠癌、前列腺癌等。体质量(BMI)作为最常用的肥胖替代指标,可较好地反映肥胖肿瘤患者的临床特征、治疗疗效及预后,然而,各临床研究得到的结论并不一致。BMI单独用于肥胖和肿瘤关系的研究有其局限与不足,临床应根据需要适当参考,尚应寻求能够反映肥胖与肿瘤间关系的更为理想的替代指标。
In recent studies,obesity has been identified as an important risk factor for several cancers,including postmenopausal breast cancer,endometrial cancer,colorectal cancer,and prostate cancer.BMI,the most common surrogate for obesity,may be a better reflection of clinical characteristics,efficacy and prognosis of patients with cancer.However,the conclusions are not all consistent.BMI has its limitations and shortcomings in clinical studies.Therefore,the best management should be made according to the clinical demands and an ideal surrogate is in the investigation.
出处
《医学综述》
2010年第22期3416-3418,共3页
Medical Recapitulate
